X0306 4 2021-04-13 0 0001566469 NantHealth, Inc. NH 0001189020 SOON-SHIONG PATRICK C/O NANTHEALTH, INC. 9920 JEFFERSON BLVD. CULVER CITY CA 90232 1 1 1 0 Chief Executive Officer 0001517764 CALIFORNIA CAPITAL EQUITY, LLC C/O NANTHEALTH, INC. 9920 JEFFERSON BLVD. CULVER CITY 90230 0 0 1 0 0001675760 NantWorks, LLC 9920 JEFFERSON BLVD. CULVER CITY CA 90230 0 0 1 0 0001629222 Cambridge Equities, LP 9920 JEFFERSON BLVD. CULVER CITY CA 90232 0 0 1 0 0001629186 MP 13 Ventures, LLC 9920 JEFFERSON BLVD. CULVER CITY CA 90232 0 0 1 0 Common Stock 2021-04-13 4 P 0 1689189 2.96 A 1689189 I See footnote Common Stock 62214114 I See footnote Common Stock 2899297 I See footnote 5.50% Convertible Senior Notes due 2021 2021-04-13 4 J 0 5000000 5000000.00 D 2021-12-15 Common Stock 411946 5000000 I See Footnote Shares are held by Cambridge Equities, LP ("Cambridge Equities"), an entity affiliated with MP 13 Ventures, LLC ("MP 13 Ventures") who is the general partner of Cambridge Equities. The reporting person is the sole member of MP 13 Ventures and has voting and dispositive power over the shares held by Cambridge Equities. Shares held by NantWorks. California Capital Equity, LLC ("CalCap") directly owns all of the equity interests of NantWorks and may be deemed to have beneficial ownership of the shares held by NantWorks. The reporting person directly owns all of the equity interests of CalCap and has voting and dispositive power over the shares held by CalCap. Shares held by NantOmics, LLC ("NantOmics"). NantWorks directly owns a majority of the equity interests of NantOmics. CalCap directly owns all of the equity interests of NantWorks and may be deemed to have beneficial ownership of the shares held by NantWorks. The reporting person directly owns all of the equity interests of CalCap and has voting and dispositive power over the shares held by CalCap. The initial conversion rate of the 5.50% Convertible Senior Notes due 2021 (the "Notes") is 82.3893 shares of common stock per $1,000 principal amount of Notes (which is equivalent to an initial conversion price of approximately $12.14 per share), subject to adjustment pursuant to the terms of the Notes. Portion of the Convertible Senior Note was forgiven as consideration for the purchase of shares reported in Table I. The Notes will be convertible at the option of the reporting persons only upon the satisfaction of certain conditions prior to the close of business on the business day immediately preceding September 15, 2021. Thereafter, the Notes will be convertible at the option of the reporting persons at any time or after September 15, 2021 until the close of business on the business day immediately preceding the maturity date. The Notes will be convertible into cash, shares of the issuer's common stock, or a combination thereof, at the issuer's election. The Notes are held by Cambridge Equities, an entity affiliated with MP 13 Ventures, LLC who is the general partner of Cambridge Equities and may be deemed to have beneficial ownership of the convertible notes held by Cambridge Equities. The reporting person is the sole member of MP 13 Ventures and has voting and dispositive power over the convertible notes held by Cambridge Equities. /s/ Patrick Soon-Shiong on behalf of himself and each other reporting person 2021-04-15